Results
|
|
1181.
|
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. [electronic resource] by
- Ting, Ru-Dee
- Keech, Anthony C
- Drury, Paul L
- Donoghoe, Mark W
- Hedley, John
- Jenkins, Alicia J
- Davis, Timothy M E
- Lehto, Seppo
- Celermajer, David
- Simes, R John
- Rajamani, Kushwin
- Stanton, Kim
Producer: 20120612
In:
Diabetes care vol. 35
Availability: No items available.
|
|
|
1182.
|
|
|
|
1183.
|
|
|
|
1184.
|
|
|
|
1185.
|
|
|
|
1186.
|
|
|
|
1187.
|
|
|
|
1188.
|
|
|
|
1189.
|
|
|
|
1190.
|
|
|
|
1191.
|
|
|
|
1192.
|
|
|
|
1193.
|
Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes. [electronic resource] by
- Saito, Tsugumichi
- Yamada, Eijiro
- Okada, Shuichi
- Shimoda, Yoko
- Tagaya, Yuko
- Hashimoto, Koshi
- Satoh, Tetsurou
- Mori, Masatomo
- Okada, Junichi
- Pessin, Jeffrey E
- Yamada, Masanobu
Producer: 20150123
In:
Endocrine journal vol. 61
Availability: No items available.
|
|
|
1194.
|
|
|
|
1195.
|
|
|
|
1196.
|
|
|
|
1197.
|
|
|
|
1198.
|
|
|
|
1199.
|
|
|
|
1200.
|
|